A limitation of the use of CPP-ACP, however, is that it cannot be used in patients with allergies to milk proteins (ACP is stabilized by casein phosphopeptides (CPP), which are proteins derived from cow milk) [5,60]. Here, NDUFAB1 is linked to allergic disease.